BRISTOL, Tenn. – Eric Carter, a former executive with GlaxoSmithKline, is the new chief science officer for King Pharmaceuticals.

Carter will oversee the drug development firm’s research, development, regulatory and medical affairs.

His most recent position was as vice president and global head for gastroenterology development and medical affairs at GSK. Earlier in his career he worked for Pharmacia & Upjohn.

At one time Carter also was a clinical associate professor at the University of North Carolina for the Division of Digestive Diseases and Nutrition, School of Medicine.